Copernicus Capital Management, LLC

SEC CIK: 0001694620
Latest filing: Nov 15, 2021

SEC filings (opens in a new tab)

FATE holding history

Fate Therapeutics Inc in every 13F filed by Copernicus Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FATE overview All 13F holders of FATE Full Q3 2021 holdings

Shares (Q3 2021): 12,000
Value: $711.0K
% of portfolio: 8.6%
Quarters held: 3; Since Q1 2021

Holdings of FATE by Copernicus Capital Management, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2021	12,000	$711.0K	8.6%	+2,000+20.0%	Added	Holders
Q2 2021	10,000	$868.0K	13.7%	+2,000+25.0%	Added	Holders
Q1 2021	8,000	$660.0K	10.7%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.